Efficacy of Aspirin in the treatment of schizophrenia
Phase 1
- Conditions
- Schizophrenia.Schizophrenia, schizotypal and delusional disorders.
- Registration Number
- IRCT201108197373N1
- Lead Sponsor
- Arak University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
age range 15-55, diagnosis of schizophrenia according to DSM4-TR criteria and clinical interview by psychiatrist, signing written informed consent, a score of at least 60 in PANSS
Exclusion criteria: pregnancy, substance abuse, severe physical disease such as kidney disease, coagulation disorders, GI disorders such as peptic ulcer, contraindications of Aspirin and inhibitors of proton pump
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PANSS. Timepoint: Before invention and every two weeks. Method of measurement: Clinical examination.
- Secondary Outcome Measures
Name Time Method Extrapyramidal and GI side effect. Timepoint: Before invention and every two weeks. Method of measurement: Clinical examination.